WHO pleas for rational antibiotic use in Asia as resistance worries mount
This article was originally published in Scrip
The Southeast Asia regional committee of the World Health Organization has made a call for the more rational use of antimicrobial agents, against a background of rising resistance problems and the emergence of "superbugs" in many countries in the area.
You may also be interested in...
First-line lung cancer approval will expand potential market for Takeda's ALK contender but the latecomer is also facing some well-established class competition in the setting.
US venture raises new funds from Asia partners as it builds a direct presence in China to develop its oncology portfolio.
Novartis gene therapy gets insurance coverage at record price although small patient population will limit system costs.